Fortrea Reports $986M Net Loss for 2025 Driven by $798M Goodwill Impairment
FTRE has more than doubled off its 52-week low of $3.97 on elevated volume (1.8× avg).
Summary
Fortrea reported a nearly $1 billion net loss for 2025, primarily due to a significant goodwill impairment, alongside weak revenue growth and ongoing legal and anti-takeover measures.
Key Events · Earnings and Guidance · FTRE
-
Massive Goodwill Impairment
The company recorded a $797.9 million goodwill impairment charge in 2025, primarily affecting its Clinical Development reporting unit, contributing significantly to the annual net loss.
-
Significant Net Loss Reported
Fortrea reported a GAAP net loss of $986.2 million for 2025, a substantial increase from the $328.5 million loss in 2024.
-
Weak Revenue Growth
Revenues for 2025 increased by a modest 1.0% to $2,723.4 million, with organic growth at 0.8%, indicating challenges in core business expansion.
-
Shareholder Class Action Lawsuit
A shareholder class action lawsuit, filed in June 2025 and amended in November 2025, alleges omissions and misrepresentations by the company and certain officers.
Analysis · FTRE · Industrial Applications And Services
Fortrea Holdings Inc. reported a substantial GAAP net loss of $986.2 million for the fiscal year ended December 31, 2025, a significant increase from the $328.5 million loss in 2024. This loss was primarily driven by a massive $797.9 million goodwill impairment charge related to its Clinical Development reporting unit. Revenue growth was weak, increasing by only 1.0% to $2,723.4 million, with organic growth at 0.8%. The company also disclosed an ongoing shareholder class action lawsuit filed in June 2025, alleging omissions and misrepresentations, which it intends to vigorously defend. Furthermore, a stockholder rights plan, adopted in June 2025 and expiring in June 2026, is in place, which could deter potential takeovers. On a positive note, the company extended its $300.0 million accounts receivable securitization program to February 2029, enhancing liquidity, and received an unqualified opinion on the effectiveness of its internal control over financial reporting.
At the time of this filing, FTRE was trading at $10.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $997.9M. The 52-week trading range was $3.97 to $18.67. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.